AMERIPRISE FINANCIAL INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 820027
MINNEAPOLIS, MN
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,175,954,602
+$149,669,066 QoQ
Shares Held
2,633,481
+16.3% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 88.31819937185801.ToString("F0")%
None 11.681800628141993.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. VRTX ranks #1 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,175,954,602 | 2,633,481 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,026,285,536 | 2,263,732 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $891,735,686 | 2,276,927 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $971,142,359 | 2,181,362 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,083,800,076 | 2,235,469 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $811,651,107 | 2,015,523 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $870,541,392 | 1,871,810 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $963,116,946 | 2,054,781 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $930,200,576 | 2,225,307 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,021,305,695 | 2,510,029 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,021,594,740 | 2,937,812 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,064,120,587 | 3,023,843 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,068,043,186 | 3,389,860 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,033,441,676 | 3,578,647 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,170,318,649 | 4,041,993 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,285,793,394 | 4,562,949 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,291,113,319 | 4,947,363 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $971,333,840 | 4,423,196 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $614,747,032 | 3,389,090 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $552,219,199 | 2,738,775 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $412,173,415 | 1,918,067 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $193,231,580 | 817,600 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $228,544,877 | 839,868 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $372,785,616 | 1,284,095 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $517,040,124 | 2,172,894 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||